New tool targets breast cancer treatment
Posted on: Monday, 2 February 2009, 15:01 CST
New York researchers have unveiled a technology tool that analyzes breast cancer tumors to determine a patient's best treatment options.
Senior Investigator Dr. Jeff Wrana of Mount Sinai Hospital and the Howard Hughes Medical Institute said the tool can predict with more than 80 per cent accuracy a patient's chance of recovering from breast cancer.
Our hope with this technology is to eventually provide individualized analysis to breast cancer patients and their oncologists so that they are better informed and empowered to select a treatment best suited to them,
Wrana said in a statement.
The technology, called DyNeMo analyzes networks of proteins in cancer cells. Analysis of more than 350 patients found those who survive breast cancer have a different organization of the network of proteins within the tumor cells, compared with patients who died following the illness.
DyNeMo can be used to predict the outcome in a newly diagnosed breast cancer patient and then assist clinicians and patients in making informed decisions on treatment.
In the future, the tool may be used to analyze other types of cancer and could be used to predict an individual's response to particular drugs.
The study was led by the Mount Sinai Hospital team and co-authored by researchers at the University of Toronto and London, England's The Institute for Cancer Research.
The findings are published in Nature Biotechnology.
Source: United Press International
Related Articles
- New Breast Cancer Drug Petitioning For Initial Treatment Use
- Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
- Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated With AERx(R) Insulin Diabetes Management System (iDMS)
- North Shore Radiation Therapy Offers Prostate Cancer Patients The Latest Tool For Precise Treatment
- MammaPrint(R) Breast Cancer Test Shown To Be Powerful Tool for Prognosis Prediction in Postmenopausal Breast Cancer Patients
- Delaware Cancer Patients Among Nation's First to Benefit From Expansion of the American Cancer Society's 'Patient Navigator Program'
- St. Louis Cancer & Breast Institute Physician Says Hormone Replacement Therapy Does Indeed Create Breast Cancer Risk
- Valeant Pharmaceuticals Announces Availability of Complimentary ``Managing Chemotherapy Side Effects For Dummies'' Cancer Chemotherapy Resource; Special Edition ``For Dummies''(R) Book Now Available for Cancer Chemotherapy Patients and Caregivers
- Patients With Treatment-Resistant Schizophrenia Get Good News Today at American Psychiatric Association Meeting in Atlanta
- Modified Cancer Therapy Regimens Offer Successful Treatments for Lymphoma With Few Side Effects
 |
 |
User Comments (0)
RSS Feeds